CAN-2409 resulted in disease-free survival improvements for patients with high-risk, localized prostate cancer. Among patients with localized prostate cancer, the viral immunotherapy CAN-2409 has ...

Credit: Getty Images Large language models leverage transformed architecture to extract and summarize unstructured electronic health record data, enabling automated retrieval of clinically relevant ...

Investigators sought to evaluate changes in the estimated CV risk of men with prostate cancer after 6 months of hormone therapy using clinical tools established for the general population.

Development and Validation of an Adapted Tool to Measure Health-Related Social Needs for the Prostate Cancer Population in Nigeria This study included 110 patients with a median age of 67 years. Most ...

The extent of residual prostate cancer in the surgical specimen following intensified neoadjuvant therapy for high-risk localized prostate cancer may predict metastatic recurrence. Residual disease ...

Assessments used to calculate cardiovascular disease risk in the general population may not have the same predictive power ...

SBRT is noninferior to traditional radiation for low- to intermediate-risk localized prostate cancer, offering a viable treatment alternative. The PACE-B study showed a 95.8% five-year rate of no ...

Long-used imaging strategies such as computed tomography (CT) and bone scintigraphy (BS) to detect lymph node and bone metastases have significant limitations and disadvantages. Newly emerging ...